Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900251322368 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Vincent Peyko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, St. Elizabeth Boardman Hospital, Boardman, OH, USA. Hauptthemen laut MEDLINE: Cystitis, Gentamicins, Premenopause, Anti-Bacterial Agents. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Lake Erie College of Medicine.
Abstract (Originalsprache)
Background
Urinary tract infections (UTI) are a disease of serious impact on every country in the world. Growing resistance has decreased the efficacy of many antimicrobial options. Aminoglycosides, like gentamicin, have long been used to treat gram-negative bacteria including UTIs.
Objectives
The goal of this study was to compare single dose gentamicin to standard oral seven-day treatment in the emergency department for uncomplicated cases of acute uncomplicated cystitis in premenopausal women.
Methods
This was a randomized, open-label clinical trial of women at least 18 years of age, that were premenopausal, non-pregnant, with clinical signs of UTI and nitrite positive urine in the emergency department. Patients received either single-dose gentamicin or standard care for 7 days. Patients were contacted by telephone at 7 and 30 days and asked about clinical resolution of their UTI. The primary outcome of this study was symptom resolution at 7 days.
Results
Among those with 7-day telephonic follow-up, self-reported symptom resolution was 83.3% (25/30) among gentamicin treated patients and 48.1% (13/27) in the standard care group (X 2 = 7.917, P = .005).
Conclusion
Single-dose gentamicin for acute uncomplicated cystitis in premenopausal, nitrite positive women was an appropriate UTI treatment and more effective than standard care for symptom resolution at 7-days in our patient population. This strategy has the potential to revolutionize treatment by offering an antibiotic with high sensitivities, high efficacy, simple administration in many different healthcare settings, 100% compliance, and increased patient satisfaction for acute cystitis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, St. Elizabeth Boardman Hospital, Boardman, OH, USA.
- Department of Pharmacy, St. Elizabeth Boardman Hospital, Boardman, OH, USA.
- Western Reserve Hospital Partners, Cuyahoga Falls, OH, USA.
ORCID-Profile: Vincent Peyko
Förderung
- Lake Erie College of Medicine
Zitieren
APA
Peyko, V., Sieger, J., & Dombroski, J. (2025). Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251322368
Vancouver
Peyko V, Sieger J, Dombroski J. Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900251322368
BibTeX
@article{Peyko2025,
author = {Peyko, Vincent and Sieger, Jacob and Dombroski, Joseph},
title = {Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900251322368}
}
EUVIMED